Thermo Fisher Scientific (TMO) Inventory Average (2012 - 2026)

Thermo Fisher Scientific has disclosed Inventory Average across 15 years of filings, most recently posting $5.5 billion for Q1 2026.

• Quarterly Inventory Average rose 7.05% year-over-year to $5.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 billion (up 7.05% YoY) and the FY2025 annual result came in at $5.2 billion, up 3.35% from the prior year.
• Inventory Average eased to $5.5 billion in Q1 2026, from $5.6 billion in the prior quarter.
• Over five years, Inventory Average peaked at $5.7 billion in Q4 2022 and troughed at $5.1 billion in Q1 2025.
• A 5-year average of $5.4 billion and a median of $5.5 billion in 2026 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2022 — Inventory Average surged 145.21% — and 2024, when it retreated 9.53%.
• Tracing TMO's Inventory Average over 5 years: stood at $5.7 billion in 2022, then slipped by 7.61% to $5.2 billion in 2023, then retreated by 0.8% to $5.2 billion in 2024, then grew by 7.32% to $5.6 billion in 2025, then dropped by 2.23% to $5.5 billion in 2026.
• Business Quant data shows TMO's Inventory Average at $5.5 billion in Q1 2026, $5.6 billion in Q4 2025, and $5.7 billion in Q3 2025.